Highlights AVITA Medical, Inc.

Equities

RCEL

US05380C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
9.61 ^USD	+3.33%		+18.64%	-29.96%

May. 31	Avita Medical's Recell Go Obtains Approval from US FDA	MT
May. 30	Sector Update: Health Care Stocks Higher in Afternoon Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Higher in Afternoon Trading	May. 30	MT
Avita Medical Shares Rise After FDA Nod For Recell Go System	May. 30	MT
Sector Update: Health Care	May. 30	MT
Avita Medical Receives FDA Premarket Approval Supplement for Recell Go System	May. 30	MT
AVITA Medical, Inc. Announces FDA Approval of RECELL GO	May. 30	CI
Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%	May. 13	MT
AVITA Medical, Inc. Provides Earnings Guidance for the Second of 2024	May. 13	CI
AVITA Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Avita Medical Lowers Q1 Revenue Guidance on Slower New Account Approvals	Apr. 10	MT
AVITA Medical, Inc. Revises Revenue Guidance for the First Quarter Ended March 31, 2024 and Full Year Fiscal 2024	Apr. 10	CI
AVITA Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
AVITA Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
AVITA Medical, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 22	CI
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on Expected Rate Cut Trajectory Insights	Jan. 11	MT
Avita Medical Signs US Distribution Agreement for Wound Healing Products	Jan. 11	MT
Avita Medical Signs Deal with Stedical Scientific for US Distribution of PermeaDerm	Jan. 10	MT
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific	Jan. 10	CI
Avita Medical, Inc. Provides Preliminary Revenue Guidance for Fourth Quarter and Full-Year 2023 and First Quarter and Year 2024	Jan. 10	CI
Avita Medical Lowers Guidance for 2023 Commercial Revenue	Nov. 20	MT
AVITA Medical, Inc. Updates Revenue Guidance for the Year 2023	Nov. 20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AVITA Medical, Inc.

Equities

RCEL

US05380C1027

Highlights

Filters